You have 9 free searches left this month | to do more

capecitabine

Capecitabine is a drug used to treat Breast Cancer, Colorectal Cancer, Gastric Cancer, and other conditions. Capecitabine is being actively studied in 285 studies and prior, has been studied in 414.

Top SponsorsTop SitesTop Investigators
Hoffmann-La RocheDana-Farber Cancer InstituteZhen Zhang
National Cancer Institute (NCI)Fairview Ridges HospitalMichele Reni
M.D. Anderson Cancer CenterMassachusetts General HospitalAiwen Wu
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Recruiting
  • Breast Cancer
  • Albumin-bound paclitaxel plus capecitabine
  • capecitabine
  • Shanghai, China
    Fudan University Shanghai Cancer center
2021-03-02
Mar 2, 2021
S
Not yet recruiting
  • Biliary Tract Cancer
  • (no location specified)
2020-12-03
Dec 3, 2020
R
Recruiting
  • Pancreatic Cancer
  • Capecitabine
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
2021-04-29
Apr 29, 2021
J
Active, not recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital, Peking University
2021-08-24
Aug 24, 2021
N
Recruiting
  • Triple Negative Breast Cancer
  • Seoul, Korea, Republic of
    Korea University, Guro hospital
2021-03-10
Mar 10, 2021
G
Not yet recruiting
  • Colorectal Cancer Metastatic
  • Capecitabine
  • +2 more
  • (no location specified)
2021-09-13
Sep 13, 2021
A
Recruiting
  • Resistant Breast Cancer
  • Non-metastatic Invasive Breast Cancer
  • Capecitabine
  • Radiotherapy
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
2021-06-03
Jun 3, 2021
N
Recruiting
  • Glioblastoma Multiforme (GBM)
  • +8 more
  • New York, New York
    Lenox Hill Brain Tumor Center
2021-08-30
Aug 30, 2021
H
Recruiting
  • Hormone Receptor-positive Breast Cancer
  • Tampa, Florida
    Moffitt Cancer Center
2021-09-29
Sep 29, 2021
C
Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
2021-08-31
Aug 31, 2021
C
Recruiting
  • Breast Neoplasm Malignant Female
  • DPD activity assessment
  • Capecitabine
  • Cagnes-sur-Mer, France
  • +4 more
2021-10-05
Oct 5, 2021
B
Completed
  • Rectal Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital
2021-07-21
Jul 21, 2021
H
Active, not recruiting
  • Squamous Cell Carcinoma of Skin
  • Carcinoma, Squamous Cell
  • Pegylated Interferon alpha-2b
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021
H
Active, not recruiting
  • Rectal Cancer
  • Rectal Adenocarcinoma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-08-13
Aug 13, 2021
F
Recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Capecitabine
  • PD-1 Antibody(Tislelizumab)
  • Shanghai, China
    Lulu@Huashan.Org.Cn
2021-03-03
Mar 3, 2021
S
Recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Capecitabine
  • Stanford, California
    Stanford University
2021-02-19
Feb 19, 2021
F
Recruiting
  • Biliary Tract Neoplasms
  • +3 more
  • Shanghai, China
    Huashan hospital
2021-04-22
Apr 22, 2021
M
Active, not recruiting
  • Pancreatic Cancer
  • Capecitabine
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-02-01
Feb 1, 2021
I
Active, not recruiting
  • Elderly Metastatic Colorectal Cancer Patients
  • Capecitabine
  • +2 more
  • Padua, Italy
    Istituto Oncologico Veneto IRCCS
2021-09-07
Sep 7, 2021
W
Recruiting
  • Recurrent Pituitary Adenomas
  • New York, New York
    Weill Cornell Medical College
2020-12-22
Dec 22, 2020
A
Completed
  • Metastatic Pancreatic Cancer
  • Capecitabine
  • +2 more
  • Amsterdam, Netherlands
    Academic Medical Center
2021-04-19
Apr 19, 2021
W
Active, not recruiting
  • Carcinoma
  • Intraperitoneal Oxaliplatin
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-11-08
Nov 8, 2021
A
Recruiting
  • RECTAL CANCER
  • Capecitabine
  • +2 more
  • Faenza, Italy
    Ospedale Degli Infermi Uo Oncologia
2021-11-15
Nov 15, 2021
B
Recruiting
  • Metastatic Colorectal Cancer
  • Seoul, Jongro-go, Korea, Republic of
    Seoul National University Hospial
2021-10-25
Oct 25, 2021